TOMSK, RUSSIA / RankWire.AI / – Russian researchers have developed and tested a bioactive coating for titanium orthopaedic implants. The material uses calcium phosphate from hydroxyapatite and contains nitrogen compounds linked to nitric oxide formation. Laboratory tests showed higher survival of human mesenchymal stem cells on coated titanium than on untreated metal. Researchers also examined surface chemistry, hardness, thickness and wettability. The peer-reviewed study focused on how different gas mixtures changed the coating and its biological response.

Scientists at Tomsk Polytechnic University produced the coatings through reactive magnetron sputtering inside a vacuum chamber. They used a hydroxyapatite target and adjusted the balance of nitrogen and argon during deposition. The team tested five gas conditions, including pure nitrogen and pure argon. Each setting produced measurable changes in the coating. Researchers assessed surface structure, chemical composition, mechanical strength and contact with liquid. They then exposed the coated titanium samples to human mesenchymal stem cells under controlled laboratory conditions.
The results showed that argon levels influenced several physical properties of the coating. Samples made with more argon became thicker, denser and harder. Chemical testing also found nitrogen-carbon and nitrogen-oxygen bonds in the modified surfaces. Researchers compared cell survival across the coated samples and untreated titanium. The coated surfaces supported significantly stronger cell survival during the study period. The team also tracked genes linked to early bone-cell development to understand how the materials affected cell behavior.
Coated titanium supports stronger cell survival
Researchers found that higher nitrogen content changed activity in some genes tied to early bone-cell differentiation. The effect appeared after seven days of cell growth. Even with those changes, the cells kept their ability to form bone-related tissue. The study did not test the coating in people. It also did not measure clinical outcomes from implanted medical devices. The findings therefore describe laboratory performance rather than proven benefits for patients receiving joint replacements or other orthopaedic implants.
Scientists from Immanuel Kant Baltic Federal University and Siberian State Medical University carried out the biomedical assessment. Researchers from Saint Petersburg State University also took part in the wider project. The work examined how coating composition affects both material performance and cell response. Hydroxyapatite is widely studied for medical coatings because its calcium phosphate structure resembles the mineral component of human bone. The researchers used that base material while varying nitrogen exposure during the coating process.
Further testing will examine longer biological effects
The research team has set out additional laboratory and biological tests following the initial seven-day assessment. Scientists plan to observe stem cells for periods between 10 and 28 days. They also intend to measure how quickly the coatings dissolve. Another part of the planned work will track nitric oxide release into surrounding tissue in living organisms. Those tests were not included in the published study. The current findings remain limited to coated titanium samples, laboratory measurements and controlled cell experiments.
The study adds data on how nitrogen and argon ratios affect calcium phosphate coatings for titanium implants. Researchers documented changes in coating thickness, density, hardness, chemical bonding and cellular response. The coated samples consistently supported better stem-cell survival than untreated titanium under the tested conditions. The research remains preclinical and does not establish safety or effectiveness in human patients. Additional studies will examine properties that the current laboratory work did not measure, including longer-term cell behavior and nitric oxide release.
